Second arrest made in Telangana counterfeit 'Levipil 500' case

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-07-15 07:18 GMT   |   Update On 2025-07-15 07:19 GMT
Advertisement

Telangana: In a major breakthrough in the ongoing crackdown on counterfeit medicines, the Drugs Control Administration (DCA) of Telangana has made a second arrest in connection with the seizure of spurious ‘Levipil 500’ tablets (Levetiracetam Tablets 500 mg) - a widely used anti-epileptic drug falsely claimed to be manufactured by Sun Pharma Laboratories Ltd.

R. Venu Gopal, a Managing Partner-cum-Competent Person of Venu Medical Agencies, was arrested and produced before the Hon’ble I Additional Judicial First Class Magistrate Court, Karimnagar. The Hon’ble I Additional Judicial First Class Magistrate Court, Karimnagar, ordered judicial remand for the accused until 23rd July, 2025, following which the accused was sent to the District Prison, Karimnagar.

As previously reported by the Medical Dialogues team, the arrest follows raids conducted by DCA officials earlier this month. On July 4, 2025, a raid was conducted at Arvind Pharma Distributors, SBI Colony, Kavadiguda, Hyderabad. The next day, on 5 th July, 2025, officials raided Venu Medical Agencies, located in Sai Nagar, Doctors Street, Karimnagar, which led to the seizure of Spurious Drug 'Levipil 500' Tablets.

Earlier, Manish Kumar, a Partner-cum-Competent Person of Arvind Pharma Distributors, had also been arrested in connection with the case.
Levipil 500 Tablet is an anti-epileptic medicine used to treat seizures (fits) in epilepsy.
Spurious drugs pose a significant threat to public health, endangering patients' well-being. These drugs not only fail to treat the intended diseases but can also lead to severe health complications over time.
Further investigation is in progress to trace the source of the counterfeit drugs and to identify others involved in this illegal activity. 

The Director General, Drugs Control Administration, Sri Shahnawaz Qasim, IPS, instructed the officers of the DCA to ensure zero tolerance towards dealers, medical shops, and pharmacies found involved in the distribution or sale of spurious or counterfeit drugs. Stringent legal action shall mandatorily be initiated against all such offenders, ensuring that they are brought to justice as per law.

The Department urges the public and all stakeholders to remain vigilant and promptly report any suspected medicines to the nearest Drugs Control office.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News